Current Report Filing (8-k)
March 12 2020 - 05:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 9, 2020
VILLAGE FARMS INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Canada
|
|
001-38783
|
|
98-1007671
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File No.)
|
|
(IRS Employee
Identification No.)
|
4700-80th Street
Delta, British Columbia Canada
V4K 3N3
(Address of
Principal Executive Offices)
(604) 940-6012
(Registrants telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of Each Class
|
|
Trading
Symbol(s)
|
|
Name of Each Exchange
on Which Registered
|
Common Shares, without par value
|
|
VFF
|
|
The Nasdaq Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 7.01
|
Regulation FD Disclosure.
|
On March 9, 2020, the Company issued a press release announcing that it had finalized its previously announced settlement agreement with
Emerald Health Therapeutics and closed the related transactions, as described in this Current Report on Form 8-K. A copy of the press release is attached as Exhibit 99.1 of this Current Report on Form 8-K and incorporated into this Item 7.01 by reference.
The information contained in this Current Report
on Form 8-K under Item 7.01, including the attached Exhibit 99.1, is being furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed to be filed
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section. The information contained in this Current Report on Form 8-K under Item 7.01, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be
expressly set forth by specific reference in such a filing.
On March 9, 2020, the Company issued a press release announcing that it had finalized its previously announced settlement agreement with
Emerald Health Therapeutics and closed the related transactions.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: March 12, 2020
|
|
|
Village Farms International, Inc.
|
|
|
By:
|
|
/s/ Michael A. DeGiglio
|
Name:
|
|
Michael A. DeGiglio
|
Title:
|
|
Chief Executive Officer and Director
|
Village Farms (NASDAQ:VFF)
Historical Stock Chart
From Feb 2024 to Mar 2024
Village Farms (NASDAQ:VFF)
Historical Stock Chart
From Mar 2023 to Mar 2024